Decreased Risk of Preeclampsia in Women with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy

[1] Seki H(2007)TNF-alpha from monocyte of patients with pre-eclampsia-induced apoptosis in human trophoblast cell line J Obstet Gynaecol Res. 33 408-416

[2] Matuoka K(2011)Comparison of magnifying chromoendoscopy and narrow-band imaging in estimation of early colorectal cancer invasion depth: a pilot study Dig Endosc. 23 118-123

[3] Inooku H(2008)Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn’s disease Clin Exp Immunol. 94 174-181

[4] Takeda S(2010)Maternal serum levels of TNF-alpha and IL-6 long after delivery in preeclamptic and normotensive pregnant women Mediators Inflamm. 2010 214-223

[5] Sakamoto T(2011)The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics Am J Gastroenterol. 106 228-233

[6] Saito Y(2009)Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy Am J Gastroenterol. 104 107-124

[7] Nakajima T(2015)The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease J Crohns Colitis. 9 286-292

[8] Matsuda T(2013)Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease Clin Gastroenterol Hepatol. 11 1508-1524

[9] Reinecker H-CSM(2019)Inflammatory bowel disease in pregnancy clinical care pathway: a report from the American Gastroenterological Association IBD Parenthood Project Working Group Gastroenterology 156 734-757

[10] Witthoeft T(2016)The Toronto Consensus statements for the management of inflammatory bowel disease in pregnancy Gastroenterology 150 363-373

[1] Seki H(2007)TNF-alpha from monocyte of patients with pre-eclampsia-induced apoptosis in human trophoblast cell line J Obstet Gynaecol Res. 33 408-416

[2] Matuoka K(2011)Comparison of magnifying chromoendoscopy and narrow-band imaging in estimation of early colorectal cancer invasion depth: a pilot study Dig Endosc. 23 118-123

[3] Inooku H(2008)Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn’s disease Clin Exp Immunol. 94 174-181

[4] Takeda S(2010)Maternal serum levels of TNF-alpha and IL-6 long after delivery in preeclamptic and normotensive pregnant women Mediators Inflamm. 2010 214-223

[5] Sakamoto T(2011)The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics Am J Gastroenterol. 106 228-233

[6] Saito Y(2009)Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy Am J Gastroenterol. 104 107-124

[7] Nakajima T(2015)The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease J Crohns Colitis. 9 286-292

[8] Matsuda T(2013)Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease Clin Gastroenterol Hepatol. 11 1508-1524

[9] Reinecker H-CSM(2019)Inflammatory bowel disease in pregnancy clinical care pathway: a report from the American Gastroenterological Association IBD Parenthood Project Working Group Gastroenterology 156 734-757

[10] Witthoeft T(2016)The Toronto Consensus statements for the management of inflammatory bowel disease in pregnancy Gastroenterology 150 363-373